Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Europe: 4 Urban communities for a Paramount Social Experience - 2Hundreds rally in West Bank against Israeli death penalty for Palestinians
- 3Poland open to German troops to help secure Ukraine ceasefire
- 4Compassion and Association: Building Significant Connections
- 5Wegovy maker Novo sharpens consumer focus with board role for Mars CEO
- Sea Ice Hits New Low in Hottest Year on Record for the Arctic
- Blue Origin's next space tourism flight will break new ground for people with disabilities
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- Getting through a Lifelong Change: Individual Examples of overcoming adversity
- Great DSLR Cameras for Photography Devotees
- Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- Figure out How to Really focus on Your Dental Inserts for Durable Outcomes
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
